Jelski Wojciech, Okrasinska Sylwia, Mroczko Barbara
Department of Biochemical Diagnostics, Medical University, Waszyngtona 15 A, 15-269 Bialystok, Poland.
Department of Biochemical Diagnostics, University Hospital, Waszyngtona 15 A, 15-269 Bialystok, Poland.
Int J Mol Sci. 2025 May 6;26(9):4395. doi: 10.3390/ijms26094395.
Breast cancer (BC) is the most common type of cancer found in women. Detection of this cancer at an early stage is essential for effective treatment and a favorable prognosis. Potential early breast cancer biomarkers useful for diagnosing these tumors are microRNAs. These are small single-stranded RNA chains that can regulate the post-transcriptional expression of many different oncogenes. Cancer cells contain miRNAs that play a special role in the etiology of cancer development. The role of microRNAs in the initiation and development of breast cancer gives us great hope for the creation of molecular tools for early cancer detection. MicroRNAs are characterized by a high stability due to RNase, which protects them from degradation and enables their detection in various biological fluids. Researchers have described multiple serum microRNA signatures useful for detecting breast cancer. This review discusses the importance and potential usefulness of microRNAs in detecting breast cancer at an early stage, predicting the course of the disease, and assessing the effectiveness of treatment.
乳腺癌(BC)是女性中最常见的癌症类型。早期发现这种癌症对于有效治疗和良好预后至关重要。对诊断这些肿瘤有用的潜在早期乳腺癌生物标志物是微小RNA。它们是小的单链RNA链,可调节许多不同癌基因的转录后表达。癌细胞含有在癌症发展病因中起特殊作用的微小RNA。微小RNA在乳腺癌发生和发展中的作用为创建早期癌症检测的分子工具带来了巨大希望。由于核糖核酸酶,微小RNA具有高度稳定性,这保护它们不被降解,并使其能够在各种生物流体中被检测到。研究人员已经描述了多种用于检测乳腺癌的血清微小RNA特征。本综述讨论了微小RNA在早期检测乳腺癌、预测疾病进程和评估治疗效果方面的重要性和潜在用途。